0001950047-24-000312.txt : 20240116 0001950047-24-000312.hdr.sgml : 20240116 20240116162332 ACCESSION NUMBER: 0001950047-24-000312 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240116 DATE AS OF CHANGE: 20240116 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Denali Therapeutics Inc. CENTRAL INDEX KEY: 0001714899 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 463872213 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38311 FILM NUMBER: 24535464 BUSINESS ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 866-8548 MAIL ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: SATO VICKI L CENTRAL INDEX KEY: 0001197020 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 940 WINTER STREET STREET 2: PERKINELMER, INC. LEGAL DEPARTMENT CITY: WALTHAM STATE: MA ZIP: 02451 144 1 primary_doc.xml 144 0001197020 XXXXXXXX LIVE 0001714899 DENALI THERAPEUTICS INC 001-38311 161 Oyster Point Blvd. South San Francisco CA 94080 6508668548 VICKI LEE SATO Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Fl. New York NY 10004

4998 92662.92 138196848 01/16/2024 NASDAQ Common 06/02/2023 Restricted Stock Units Issuer N 4998 06/02/2023 N/A N 10b5-1 Sales for VICKI LEE SATO

161 Oyster Point Blvd. South San Francisco CA 94080

Common 12/15/2023 1666 38967.74 10b5-1 Sales for VICKI LEE SATO

161 Oyster Point Blvd. South San Francisco CA 94080

Common 11/15/2023 1666 31870.58 The securities to be sold were acquired upon the vesting of restricted stock units during the period of 4/17/2015 through 6/2/2023. 01/16/2024 03/27/2023 /s/ Vicki Lee Sato